表紙:医薬品包装の世界市場 (~2026年):原材料 (プラスチック・紙&板紙・ガラス・金属)・タイプ (ペットボトル・ブリスター・キャップ&クロージャー・ラベル&付属品・充填済みシリンジ)・投薬経路・地域別
市場調査レポート
商品コード
1017723

医薬品包装の世界市場 (~2026年):原材料 (プラスチック・紙&板紙・ガラス・金属)・タイプ (ペットボトル・ブリスター・キャップ&クロージャー・ラベル&付属品・充填済みシリンジ)・投薬経路・地域別

Pharmaceutical Packaging Market by Raw Material (Plastics, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Pre-filled syringes), Drug Delivery, and Region - Global Forecast to 2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 269 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.25円
医薬品包装の世界市場 (~2026年):原材料 (プラスチック・紙&板紙・ガラス・金属)・タイプ (ペットボトル・ブリスター・キャップ&クロージャー・ラベル&付属品・充填済みシリンジ)・投薬経路・地域別
出版日: 2021年07月05日
発行: MarketsandMarkets
ページ情報: 英文 269 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の医薬品包装の市場規模は予測期間中14.5%のCAGRで推移し、2021年の999億米ドルから、2026年には1968億米ドルの規模に成長すると予測されています。

新興市場では、医療へのアクセスの向上、医療費の増加、健康的なライフスタイルに対する消費者の意識の高まりなどを背景に、医薬品包装の需要がますます高まっています。さらに、高度な薬物送達や、患者の利便性とコンプライアンスを向上させる革新的なパッケージングソリューションが市場成長を牽引しています。さらに、癌や感染症などの慢性疾患の増加、高齢化社会に伴う患者に優しい先進的な包装へのニーズなどの要因も予測期間中の市場成長を牽引すると予測されています。

原料別では、プラスチックの部門が最大のシェアを示しています。また、タイプ別では、プラスチックボトルの部門が最大のシェアを示しています。さらに、投薬経路別では、経口投薬の部門が2021年に最大の規模を示す見通しです。

当レポートでは、世界の医薬品包装の市場を調査し、市場の定義と概要、バリューチェーン、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、技術・特許の分析、ケーススタディ、市場規模の推移・予測、原材料・タイプ・投薬経路・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • ケーススタディ
  • マクロ経済指標
  • 関税・規制
  • 技術分析
  • 価格分析
  • エコシステム
  • COVID-19の影響
  • 顧客の事業に影響を与える動向
  • 特許分析
  • 原材料分析
  • 貿易分析
  • 運用データ

第6章 市場分析・予測:原材料別

  • プラスチック
    • 高密度ポリエチレン
    • ポリエステル
    • ポリプロピレン
    • 低密度ポリエチレン
    • ポリ塩化ビニル
    • 環状オレフィンコポリマー
    • ポリエチレンテレフタレート
  • 紙・板紙
  • ガラス
  • 金属
  • その他

第7章 市場分析・予測:タイプ別

  • ペットボトル
    • 標準型ペットボトル
    • プラスチックディスペンシングボトル
    • プラスチックジャー
  • ブリスターパック
    • コンパートメントパック
    • ウォレットパック
  • ラベル・アクセサリー
  • キャップ・クロージャー
  • 医療用専用バッグ
  • 事前充填注射器
  • 温度管理パッケージ
  • ポーチ&ストリップパック
  • アンプル
  • バイアル
  • 事前充填吸入器
    • 定量吸入器
    • ドライパウダー吸入器
  • 薬用チューブ
    • 複合チューブ
    • 全プラスチックチューブ
    • 折りたたみ式金属チューブ
  • 瓶・キャニスター
  • カートリッジ
  • その他

第8章 市場分析・予測:投薬経路別

  • 経口
  • 経肺
  • 経皮
  • 注射
  • 局所
  • 経鼻
  • 点眼
  • IV
  • その他

第9章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • 中東・アフリカ

第10章 競合情勢

  • 収益分析
  • 市場シェア分析
  • 主要企業のランキング
  • 競合評価クアドラント
  • 競合シナリオ・動向

第11章 企業プロファイル

  • BERRY GLOBAL INC.
  • GERRESHEIMER AG
  • AMCOR PLC
  • SCHOTT AG
  • APTARGROUP, INC.
  • BECTON, DICKINSON AND COMPANY
  • CATALENT, INC.
  • NIPRO CORPORATION
  • WEST PHARMACEUTICAL SERVICES, INC.
  • WESTROCK COMPANY
  • その他
    • ALPLA WERKE ALWIN LEHNER GMBH & CO KG
    • ARDAGH GROUP S. A.
    • CCL INDUSTRIES INC.
    • FRANK NOE EGYPT LTD
    • GAPLAST GMBH
    • LONZA GROUP LTD
    • MONDI GROUP
    • NOLATO AB
    • ORIGIN PHARMA PACKAGING
    • COMAR
    • PAREKHPLAST INDIA LTD.
    • SGD PHARMA
    • SILGAN HOLDINGS INC.
    • STEVANATO GROUP
    • VETTER PHARMA INTERNATIONAL GMBH

第12章 隣接市場・関連市場

第13章 付録

目次
Product Code: CH 3482

The global pharmaceutical packaging market size is projected to reach USD 196.8 billion by 2026 from USD 99.9 billion in 2021, at a CAGR of 14.5% during the forecast period. The ever-increasing demand for pharmaceutical packaging in emerging markets owing to better access to healthcare, rising healthcare expenses, and growing consumer awareness regarding healthier lifestyle. Additionally, advanced drug delivery and innovative packaging solutions with higher patient convenience and compliance drive the market for pharmaceutical packaging. Rising occurrences of chronic diseases such as cancer, infectious diseases, and others and rising aging population necessitating advanced and patient friendly packaging are also expected to drive the market for pharmaceutical packaging during the forecast period.

Plastics accounted for the largest share amongst other raw material in the pharmaceutical packaging market

Plastics are extensively used as raw materials for pharmaceutical packaging. Plastic offers freedom of design and cost-effective solution, making it a highly compatible solution for pharmaceutical packaging. The exceptional shatter resistance provided by plastics enables ease of handling and transportation. In addition, plastics can be attributed to their easy moldability, strength, and effective barrier against gas and vapor.

Plastic bottles accounted for the largest market share amongst other types in the pharmaceutical packaging market

Plastic bottles are suitable for storage of drugs in liquid and solid forms and can be coupled with the required type of cap & closure to suit specific applications such as nasal spray and ophthalmic drops. Growing use of oral drug delivery mode owing to patient compliance and convenience, increasing cases of communicable diseases, and rise in aging population in developed economies are responsible for the high share of the bottles segment.

Oral is expected to be the largest pharmaceutical packaging drug delivery mode in 2021 amongst others.

Oral drug delivery mode is estimated to be the largest category in the overall pharmaceutical packaging market. This large market size can be attributed to the convenience in usage, increased incidence of chronic diseases, improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, and heavy investments made by big pharmaceutical players for enhancing in-house capabilities to develop oral drug delivery technologies.

APAC is projected to grow the fastest in the pharmaceutical packaging market during the forecast period.

APAC is predicted to be the fastest-growing region amongst others in the pharmaceutical packaging market in 2020, in terms of value. Increasing government initiatives in emerging pharmaceutical market, increase in contract manufacturing activities, rise in aging population, and increased spending on healthcare are driving the market in APAC. China, Australia, Japan, South Korea, and India are the major markets in this region. In addition, growing technological advancements in healthcare sector in countries such as Singapore, China, Malaysia, Thailand, and others, increasing urbanization, and changing lifestyle are also some of the driving factors for the market growth in pharmaceutical packaging industry.

Extensive primary interviews were conducted in the process of determining and verifying sizes of several segments and subsegments of the pharmaceutical packaging market gathered through secondary research.

The breakdown of primary interviews has been given below.

  • By Company Type: Tier 1 - 25%, Tier 2 - 50%, and Tier 3 - 25%
  • By Designation: C Level Executives - 20%, Director Level - 30%, Others - 50%
  • By Region: North America - 20%, APAC - 25%, Europe - 30%, Middle East & Africa - 10%, South America-15%.

The key players in this market are Schott AG (Germany), Amcor (Switzerland), Aptar Group (US), West Pharmaceutical Services, Inc. (US), Berry Global (US), Gerresheimer AG (Germany), Catalent (US), and WestRock (US). The pharmaceutical packaging market report analyzes the key growth strategies, such as new product launches, investments & expansions, agreements, partnerships, and mergers & acquisitions to strengthen their market positions.

Research Coverage

This report covers the pharmaceutical packaging market and forecasts its market size until 2026. The market has been segmented based on raw material, type, drug delivery, and region. The report also provides detailed information on company profiles and competitive strategies adopted by the key players to strengthen their positions in the market. The report also provides insights into the driving and restraining factors in the pharmaceutical packaging market, along with opportunities and challenges across these industries. It also includes profiles for top manufacturers in the market.

Reasons to Buy the Report

The report is expected to help market leaders/new entrants in the following ways:

1. This report segments the pharmaceutical packaging market and provides the closest approximations of overall market size for its segments across different verticals and regions.

2. This report is expected to help stakeholders understand the pulse of the market and provide information on key drivers, restraints, challenges, and opportunities influencing the growth of the market.

3. This report is expected to help stakeholders obtain an in-depth understanding of the competitive landscape of the market and gain insights to improve the position of their businesses. The competitive landscape section includes detailed information on strategies, such as new product launches, investments & expansions, agreements, partnerships, and mergers & acquisitions.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 PHARMACEUTICAL PACKAGING MARKET SEGMENTATION
    • 1.3.2 REGIONS COVERED
    • FIGURE 2 PHARMACEUTICAL PACKAGING , REGIONAL SEGMENTATION
    • 1.3.3 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 UNIT CONSIDERED
  • 1.6 STAKEHOLDERS
  • 1.7 LIMITATIONS
  • 1.8 INCLUSIONS & EXCLUSIONS
    • TABLE 1 PHARMACEUTICAL PACKAGING MARKET: INCLUSIONS & EXCLUSIONS
  • 1.9 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 3 PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • 2.1.3 PRIMARY LIST
      • 2.1.3.1 Key data from primary sources
      • 2.1.3.2 Key industry insights
      • 2.1.3.3 Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • FIGURE 4 PHARMACEUTICAL PACKAGING MARKET: BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
    • FIGURE 5 PHARMACEUTICAL PACKAGING MARKET: TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION
    • FIGURE 6 PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION
    • 2.3.1 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH PRIMARY INTERVIEWS
    • 2.3.2 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH SECONDARY SOURCES
    • FIGURE 7 PHARMACEUTICAL PACKAGING MARKET ANALYSIS
  • 2.4 RESEARCH LIMITATIONS
  • 2.5 ASSUMPTIONS
  • 2.6 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
    • 2.6.1 SUPPLY SIDE
    • 2.6.2 DEMAND SIDE
    • 2.6.3 INSIGHTS FROM KEY RESPONDENTS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

    • FIGURE 8 PLASTICS WAS THE LARGEST RAW MATERIAL SEGMENT FOR PHARMACEUTICAL PACKAGING IN 2020
    • FIGURE 9 PLASTIC BOTTLES TO BE THE LARGEST TYPE OF PHARMACEUTICAL PACKAGING
    • FIGURE 10 ORAL DRUG DELIVERY TO BE THE LARGEST DRUG DELIVERY MODE IN PHARMACEUTICAL PACKAGING
    • FIGURE 11 APAC TO BE THE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES IN THE PHARMACEUTICAL PACKAGING MARKET
    • FIGURE 12 GROWING DEMAND FOR PHARMACEUTICAL PACKAGING IN EMERGING ECONOMIES TO DRIVE THE MARKET
  • 4.2 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY
    • FIGURE 13 ORAL DRUG DELIVERY TO BE THE LARGEST SEGMENT IN THE PHARMACEUTICAL PACKAGING MARKET
  • 4.3 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
    • FIGURE 14 PLASTIC BOTTLES TO BE THE LARGEST TYPE OF PHARMACEUTICAL PACKAGING
  • 4.4 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
    • FIGURE 15 PLASTICS TO BE THE LARGEST RAW MATERIAL FOR PHARMACEUTICAL PACKAGING
  • 4.5 PHARMACEUTICAL PACKAGING MARKET, BY MAJOR COUNTRIES
    • FIGURE 16 INDIA TO RECORD THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • 4.6 APAC PHARMACEUTICAL PACKAGING MARKET, BY TYPE AND COUNTRY
    • FIGURE 17 PLASTIC BOTTLES AND CHINA ACCOUNTED FOR THE LARGEST MARKET SHARES IN 2019

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE PHARMACEUTICAL PACKAGING MARKET
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing healthcare expenditure and pharmaceutical industry in emerging economies
      • 5.2.1.2 Growing demand for drug delivery devices and blister packaging
      • 5.2.1.3 Technological advancements to contribute to growth of pharmaceutical packaging
        • 5.2.1.3.1 Nanomedicine and Nano Drug Delivery Systems (NDDS)
        • 5.2.1.3.2 Child-resistant packaging
        • 5.2.1.3.3 Radio-Frequency Identification (RFID)
        • 5.2.1.3.4 Micro pump technology
        • 5.2.1.3.5 Eco-friendly and sustainable packaging
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Increasing overall packaging costs owing to dynamic regulatory policies
      • 5.2.2.2 Lack of access to proper healthcare
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing demand for primary pharmaceutical packaging
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Safeguarding against counterfeit products
  • 5.3 VALUE CHAIN ANALYSIS
    • FIGURE 19 OVERVIEW OF VALUE CHAIN OF PHARMACEUTICAL PACKAGING MARKET
    • 5.3.1 RAW MATERIAL SUPPLIERS
    • 5.3.2 R&D OF PRODUCTS
    • 5.3.3 MANUFACTURERS
    • 5.3.4 DISTRIBUTORS
    • 5.3.5 END-USERS
  • 5.4 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 20 PORTER'S FIVE FORCES ANALYSIS: PHARMACEUTICAL PACKAGING MARKET
    • 5.4.1 THREAT OF NEW ENTRANTS
    • 5.4.2 THREAT OF SUBSTITUTES
    • 5.4.3 BARGAINING POWER OF BUYERS
    • 5.4.4 BARGAINING POWER OF SUPPLIERS
    • 5.4.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.5 CASE STUDY ANALYSIS
    • 5.5.1 MOISTURE BARRIER TECHNOLOGY FOR BETTER DRUG DELIVERY
    • 5.5.2 EMPLOYING CUSTOM TECHNOLOGY FOR BETTER BREATHING
  • 5.6 MACROECONOMIC INDICATORS
    • 5.6.1 GLOBAL GDP TRENDS
    • TABLE 2 GDP OF KEY COUNTRIES, USD BILLION, 2016-2019
    • TABLE 3 GDP GROWTH ESTIMATE AND PROJECTION OF KEY COUNTRIES, 2019-2022
    • TABLE 4 CURRENT HEALTH EXPENDITURE (% OF GDP) OF KEY COUNTRIES, 2018
  • 5.7 TARIFFS & REGULATIONS
    • 5.7.1 REGULATIONS
      • 5.7.1.1 Europe
      • 5.7.1.2 US
      • 5.7.1.3 Others
  • 5.8 TECHNOLOGY ANALYSIS
    • 5.8.1 NANOTECHNOLOGY
    • 5.8.2 PACKAGING FOR BIOLOGICS
    • 5.8.3 SMART PACKAGING
    • 5.8.4 OTHER SMART TRENDS AND TECHNOLOGIES: PHARMACEUTICAL PACKAGING INNOVATIONS
  • 5.9 PRICE ANALYSIS
    • FIGURE 21 PRICE OF RAW MATERIALS USED IN PHARMACEUTICAL PACKAGING
  • 5.10 ECOSYSTEM
    • FIGURE 22 PHARMACEUTICAL PACKAGING ECOSYSTEM
  • 5.11 IMPACT OF COVID-19 ON THE PHARMACEUTICAL PACKAGING MARKET
    • 5.11.1 CONFIRMED CASES AND DEATHS, BY GEOGRAPHY
    • FIGURE 23 PACE OF GLOBAL PROPAGATION OF COVID-19 IS UNPRECEDENTED
    • 5.11.2 IMPACT ON HEALTHCARE INDUSTRY
  • 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
    • FIGURE 24 SUSTAINABLE PACKAGING, IOT, NANOTECHNOLOGY TO DRIVE FUTURE GROWTH
  • 5.13 PATENT ANALYSIS
    • 5.13.1 INTRODUCTION
    • 5.13.2 METHODOLOGY
    • 5.13.3 DOCUMENT TYPE
    • FIGURE 25 PATENTS REGISTERED (2010 TO 2020)
    • 5.13.4 PUBLICATION TRENDS - LAST 10 YEARS
    • FIGURE 26 NUMBER OF PATENTS IN LAST 10 YEARS
    • 5.13.5 INSIGHT
    • 5.13.6 JURISDICTION ANALYSIS
    • FIGURE 27 TOP JURISDICTIONS
    • 5.13.7 TOP COMPANIES/APPLICANTS
    • FIGURE 28 TOP APPLICANTS IN THE MARKET
    • TABLE 5 LIST OF PATENTS BY SANOFI AVENTIS DEUTSCHLAND
    • TABLE 6 LIST OF PATENTS BY ICU MEDICAL INC.
    • TABLE 7 LIST OF PATENTS BY TERUMO CORP
    • TABLE 8 LIST OF PATENTS BY BECTON DICKINSON AND COMPANY
    • TABLE 9 TOP 10 PATENT OWNERS (US) IN LAST 10 Y EARS
  • 5.14 RAW MATERIAL ANALYSIS
    • 5.14.1 PLASTICS
    • 5.14.2 PAPER
    • 5.14.3 GLASS
    • 5.14.4 METAL
  • 5.15 TRADE ANALYSIS
  • 5.16 OPERATIONAL DATA

6 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL

  • 6.1 INTRODUCTION
    • TABLE 10 BASIC PACKAGING RAW MATERIAL USED IN PHARMACEUTICAL PACKAGING
    • FIGURE 29 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
    • TABLE 11 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2017-2024 (USD MILLION)
    • TABLE 12 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL/REGION, 2017-2024 (USD MILLION)
    • TABLE 13 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2019-2026 (KILOTON)
    • TABLE 14 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2019-2026 (USD MILLION)
    • TABLE 15 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL/REGION, 2019-2026 (KILOTON)
    • TABLE 16 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL/REGION, 2019-2026 (USD MILLION)
  • 6.2 PLASTICS
    • 6.2.1 EXCELLENT SHATTER RESISTANCE OF PLASTICS & POLYMERS BOOSTS ITS USE IN PRIMARY PACKAGING
    • TABLE 17 PLASTIC PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL/REGION, 2019-2026 (KILOTON)
    • TABLE 18 PLASTIC PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL/REGION, 2019-2026 (USD MILLION)
    • 6.2.2 HIGH-DENSITY POLYETHYLENE
    • 6.2.3 POLYESTER
    • 6.2.4 POLYPROPYLENE
    • 6.2.5 LOW-DENSITY POLYETHYLENE
    • 6.2.6 POLYVINYL CHLORIDE
    • 6.2.7 CYCLIC OLEFIN COPOLYMER
    • 6.2.8 POLYETHYLENE TEREPHTHALATE
  • 6.3 PAPER & PAPERBOARD
    • 6.3.1 INNOVATIONS IN SECONDARY PACKAGING TO PROPEL THE USE OF PAPER & PAPERBOARD
    • TABLE 19 PAPER & PAPERBOARD PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL/REGION, 2019-2026 (KILOTON)
    • TABLE 20 PAPER & PAPERBOARD PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL/REGION, 2019-2026 (USD MILLION)
  • 6.4 GLASS
    • 6.4.1 EXCELLENT CHEMICAL RESISTANCE OF GLASS TO BOOST ITS USE IN PRIMARY PACKAGING
    • TABLE 21 GLASS PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL/REGION, 2019-2026 (KILOTON)
    • TABLE 22 GLASS PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL/REGION, 2019-2026 (USD MILLION)
    • TABLE 23 TYPE OF GLASS USED FOR DIFFERENT PACKAGING
  • 6.5 METALS
    • 6.5.1 INCREASING USE OF ALUMINUM FOR BLISTER PACKAGING TO BOOST THE MARKET FOR METALS SEGMENT
    • TABLE 24 METAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL/REGION, 2019-2026 (KILOTON)
    • TABLE 25 METAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL/REGION, 2019-2026 (USD MILLION)
  • 6.6 OTHERS
    • TABLE 26 OTHER RAW MATERIAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL/REGION, 2019-2026 (KILOTON)
    • TABLE 27 OTHER RAW MATERIAL PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL/REGION, 2019-2026 (USD MILLION)

7 PHARMACEUTICAL PACKAGING MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 28 PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
    • TABLE 29 PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 30 PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 31 PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2017-2024 (USD MILLION)
    • TABLE 32 PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 33 PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2019-2026 (USD MILLION)
    • FIGURE 30 PLASTIC BOTTLES ACCOUNTED FOR THE LARGEST SHARE IN THE OVERALL PHARMACEUTICAL PACKAGING MARKET
  • 7.2 PLASTIC BOTTLES
    • 7.2.1 EASY OPERABILITY, SHATTER RESISTANCE, AND LIGHTWEIGHT PROPERTIES TO DRIVE THE DEMAND
    • TABLE 34 HISTORIC PLASTIC BOTTLES MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
    • TABLE 35 PLASTIC BOTTLES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • 7.2.2 STANDARD PLASTIC BOTTLES
    • 7.2.3 PLASTIC DISPENSING BOTTLES
    • 7.2.4 PLASTIC JARS
  • 7.3 BLISTER PACKS
    • 7.3.1 EFFECTIVE DRUG PROTECTION AND EASY MANUFACTURING TO DRIVE BLISTER PACKS MARKET
    • TABLE 36 BLISTER PACKAGING MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
    • TABLE 37 BLISTER PACKAGING MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • 7.3.2 COMPARTMENT PACKS
    • 7.3.3 WALLET PACKS
  • 7.4 LABELS & ACCESSORIES
    • 7.4.1 PATIENT-DRUG COMMUNICATION COMPLIANCE DRIVING DEMAND
    • TABLE 38 LABELS & ACCESSORIES MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
    • TABLE 39 LABELS & ACCESSORIES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.5 CAPS & CLOSURES
    • 7.5.1 INCREASED DEMAND FOR TAMPER-EVIDENT PACKAGING TO BOOST GROWTH
    • TABLE 40 CAPS & CLOSURES MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
    • TABLE 41 CAPS & CLOSURES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.6 MEDICAL SPECIALTY BAGS
    • 7.6.1 EASY HANDLING AND DISPOSABLE CHARACTERISTICS DRIVING THE DEMAND
    • TABLE 42 MEDICAL SPECIALTY BAGS MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
    • TABLE 43 MEDICAL SPECIALTY BAGS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.7 PRE-FILLED SYRINGES
    • 7.7.1 SELF-MEDICATION AND INCREASING CHRONIC DISEASES DRIVING THE DEMAND
    • TABLE 44 PRE-FILLED SYRINGES MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
    • TABLE 45 PRE-FILLED SYRINGES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.8 TEMPERATURE CONTROLLED PACKAGING
    • 7.8.1 INCREASED MANUFACTURING OF SPECIALIZED DRUGS TO FUEL MARKET GROWTH
    • TABLE 46 TEMPERATURE CONTROLLED VACCINES/MEDICINES PACKAGING MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
    • TABLE 47 TEMPERATURE CONTROLLED VACCINES/MEDICINES PACKAGING MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.9 POUCHES & STRIP PACKS
    • 7.9.1 INCREASING DEMAND FOR STAND-UP POUCHES OFFERS GROWTH PROSPECTS
    • TABLE 48 POUCHES & STRIP PACKS MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
    • TABLE 49 POUCHES & STRIP PACKS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.10 AMPOULES
    • 7.10.1 INCREASING DEMAND FROM DEVELOPING COUNTRIES TO DRIVE GROWTH
    • TABLE 50 AMPOULES MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
    • TABLE 51 AMPOULES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.11 VIALS
    • 7.11.1 DEMAND FOR VIALS IN VACCINE PACKAGING DRIVING THE DEMAND
    • TABLE 52 VIALS MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
    • TABLE 53 VIALS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.12 PRE-FILLED INHALERS
    • 7.12.1 HIGHER DEMAND OWING TO INCREASING CASES OF PULMONARY DISEASES
    • TABLE 54 PRE-FILLED INHALERS MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
    • TABLE 55 PRE-FILLED INHALERS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • 7.12.2 METERED DOSE INHALERS
    • 7.12.3 DRY POWDER INHALERS
  • 7.13 MEDICATION TUBES
    • 7.13.1 EASE OF USE IS DRIVING THE DEMAND FOR MEDICATION TUBES
    • TABLE 56 MEDICATION TUBES MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
    • TABLE 57 MEDICATION TUBES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • 7.13.2 COMPOSITE TUBES
    • 7.13.3 ALL-PLASTIC TUBES
    • 7.13.4 COLLAPSIBLE METAL TUBES
  • 7.14 JARS & CANISTERS
    • 7.14.1 EFFECTIVE BARRIER PROPERTIES TO PROPEL THE DEMAND FOR JARS & CANISTERS
    • TABLE 58 JARS & CANISTERS MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
    • TABLE 59 JARS & CANISTERS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.15 CARTRIDGES
    • 7.15.1 INCREASING USE OF SPECIALIZED PRE-FILLED SYRINGES DRIVING THE DEMAND
    • TABLE 60 CARTRIDGES MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
    • TABLE 61 CARTRIDGES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.16 OTHERS
    • TABLE 62 OTHERS MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
    • TABLE 63 OTHER TYPES, MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)

8 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY

  • 8.1 INTRODUCTION
    • FIGURE 31 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE (2021-2026)
    • TABLE 64 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY/REGION, 2017-2024 (USD MILLION)
    • TABLE 65 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE, 2017-2024 (USD MILLION)
    • TABLE 66 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY/REGION, 2019-2026 (USD MILLION)
    • TABLE 67 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2019-2026 (USD MILLION)
  • 8.2 ORAL DRUG DELIVERY PACKAGING
    • 8.2.1 HIGH DEMAND FOR ORAL DRUG DELIVERY OWING TO EASE OF USE
    • TABLE 68 ORAL DRUG DELIVERY, PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 8.3 PULMONARY DRUG DELIVERY PACKAGING
    • 8.3.1 INCREASING CASES OF LUNG-RELATED DISEASES DRIVING THE DEMAND
    • TABLE 69 PULMONARY DRUG DELIVERY, PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 8.4 TRANSDERMAL DRUG DELIVERY PACKAGING
    • 8.4.1 INCREASING SMALL DOSE DRUG USE FUELING MARKET FOR TRANSDERMAL DRUG DELIVERY PACKAGING
    • TABLE 70 TRANSDERMAL DRUG DELIVERY, PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 8.5 INJECTABLE PACKAGING
    • 8.5.1 HIGH BIOAVAILABILITY AND EFFICIENT TREATMENT DRIVING THE DEMAND
    • TABLE 71 INJECTABLE DRUG DELIVERY, PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 8.6 TOPICAL DRUG DELIVERY PACKAGING
    • 8.6.1 PREVALENCE OF SKIN DISEASES DRIVING THE MARKET FOR TOPICAL FORMULATIONS
    • TABLE 72 TOPICAL DRUG DELIVERY, PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 8.7 NASAL DRUG DELIVERY PACKAGING
    • 8.7.1 RAPID ABSORPTION AND FASTER ONSET OF ACTION PROPELLING THE USE
    • TABLE 73 NASAL DRUG DELIVERY, PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 8.8 OCULAR DRUG DELIVERY PACKAGING
    • 8.8.1 INCREASING PREVALENCE OF EYE DISORDERS AND AGING POPULATION EXPECTED TO FUEL CONSUMPTION
    • TABLE 74 OCULAR DRUG DELIVERY, PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 8.9 IV DRUGS DELIVERY PACKAGING
    • 8.9.1 IMPROVED PATIENT COMPLIANCE AND HIGH DRUG DOSE CAPABILITY DRIVING THE DEMAND
    • TABLE 75 IV DRUG DELIVERY, PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 8.10 OTHER DRUGS DELIVERY PACKAGING
    • TABLE 76 OTHER DRUG DELIVERY, PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2019-2026 (USD MILLION)

9 PHARMACEUTICAL PACKAGING MARKET, BY REGION

  • 9.1 INTRODUCTION
    • FIGURE 32 PHARMACEUTICAL PACKAGING MARKET IN INDIA TO REGISTER HIGHEST CAGR
    • TABLE 77 PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2017-2024 (USD MILLION)
    • TABLE 78 PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 33 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
    • TABLE 79 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2017-2024 (USD MILLION)
    • TABLE 80 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 81 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2017-2024 (USD MILLION)
    • TABLE 82 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 83 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 84 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2019-2026 (USD MILLION)
    • TABLE 85 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2019-2026 (USD MILLION)
    • TABLE 86 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2019-2026 (KILOTON)
    • TABLE 87 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2019-2026 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 Rapid technological advancements to drive growth
    • TABLE 88 US: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 89 US: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Competitive business environment boosts the market
    • TABLE 90 CANADA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 91 CANADA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • 9.2.3 MEXICO
      • 9.2.3.1 Government initiatives in the healthcare industry aiding high demand
    • TABLE 92 MEXICO: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 93 MEXICO: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 94 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2017-2024 (USD MILLION)
    • TABLE 95 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 96 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2017-2024 (USD MILLION)
    • TABLE 97 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 98 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 99 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2019-2026 (USD MILLION)
    • TABLE 100 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2019-2026 (USD MILLION)
    • TABLE 101 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2019-2026 (KILOTON)
    • TABLE 102 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2019-2026 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Increasing aging population and non-communicable diseases is major driver for growth
    • TABLE 103 GERMANY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 104 GERMANY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • 9.3.2 FRANCE
      • 9.3.2.1 The demand for generic drugs in the country is driving the growth
    • TABLE 105 FRANCE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 106 FRANCE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • 9.3.3 ITALY
      • 9.3.3.1 Growing exports of pharmaceuticals impacting market growth
    • TABLE 107 ITALY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 108 ITALY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • 9.3.4 UK
      • 9.3.4.1 Innovations in drug manufacturing increasing the demand
    • TABLE 109 UK: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 110 UK: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Government initiatives in the healthcare sector to boost the demand
    • TABLE 111 SPAIN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 112 SPAIN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • 9.3.6 RUSSIA
      • 9.3.6.1 Government initiatives for domestic production of pharmaceuticals are driving the market
    • TABLE 113 RUSSIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 114 RUSSIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • 9.3.7 REST OF EUROPE
    • TABLE 115 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 116 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
  • 9.4 APAC
    • FIGURE 34 APAC: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
    • TABLE 117 APAC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2017-2024 (USD MILLION)
    • TABLE 118 APAC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 119 APAC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2017-2024 (USD MILLION)
    • TABLE 120 APAC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 121 APAC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 122 APAC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2019-2026 (USD MILLION)
    • TABLE 123 APAC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2019-2026 (USD MILLION)
    • TABLE 124 APAC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2019-2026 (KILOTON)
    • TABLE 125 APAC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2019-2026 (USD MILLION)
    • 9.4.1 CHINA
      • 9.4.1.1 Increased investments in R&D of biologics and biosimilar drugs driving the market
    • TABLE 126 CHINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 127 CHINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Sizeable aging population increasing the demand for medications
    • TABLE 128 JAPAN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 129 JAPAN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • 9.4.3 SOUTH KOREA
      • 9.4.3.1 Well-developed healthcare industry and presence of major pharmaceuticals manufacturers driving the market
    • TABLE 130 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 131 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • 9.4.4 INDIA
      • 9.4.4.1 Large domestic consumption and export of generic drugs driving the market
    • TABLE 132 INDIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 133 INDIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Medicare and PBS schemes strengthening the country's pharmaceutical industry
    • TABLE 134 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 135 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • 9.4.6 REST OF APAC
    • TABLE 136 REST OF APAC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 137 REST OF APAC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
  • 9.5 SOUTH AMERICA
    • TABLE 138 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2017-2024 (USD MILLION)
    • TABLE 139 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 140 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2017-2024 (USD MILLION)
    • TABLE 141 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 142 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 143 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2019-2026 (USD MILLION)
    • TABLE 144 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2019-2026 (USD MILLION)
    • TABLE 145 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2019-2026 (KILOTON)
    • TABLE 146 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2019-2026 (USD MILLION)
    • 9.5.1 BRAZIL
      • 9.5.1.1 Free and universal healthcare services supporting the growth of the pharmaceutical industry
    • TABLE 147 BRAZIL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 148 BRAZIL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • 9.5.2 ARGENTINA
      • 9.5.2.1 The population has good access to generic drugs supported by government initiatives
    • TABLE 149 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 150 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • 9.5.3 REST OF SOUTH AMERICA
    • TABLE 151 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 152 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • TABLE 153 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2017-2024 (USD MILLION)
    • TABLE 154 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 155 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2017-2024 (USD MILLION)
    • TABLE 156 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 157 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 158 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2019-2026 (USD MILLION)
    • TABLE 159 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2019-2026 (USD MILLION)
    • TABLE 160 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2019-2026 (KILOTON)
    • TABLE 161 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2019-2026 (USD MILLION)
    • 9.6.1 SAUDI ARABIA
      • 9.6.1.1 Wider access to healthcare services is increasing the demand for pharmaceuticals
    • TABLE 162 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD MILLION)
    • TABLE 163 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • 9.6.2 SOUTH AFRICA
      • 9.6.2.1 Gradual rise in generic drug use to fuel the pharmaceutical packaging market
    • TABLE 164 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD THOUSAND)
    • TABLE 165 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • 9.6.3 UAE
      • 9.6.3.1 Increasing initiatives for domestic pharmaceutical production driving market growth
    • TABLE 166 UAE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
    • 9.6.4 REST OF THE MIDDLE EAST & AFRICA
    • TABLE 167 REST OF THE MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2017-2024 (USD THOUSAND)
    • TABLE 168 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • 10.1.1 PHARMACEUTICAL PACKAGING MARKET, KEY DEVELOPMENTS
    • TABLE 169 OVERVIEW OF STRATEGIES ADOPTED BY KEY PHARMACEUTICAL PACKAGING PLAYERS
  • 10.2 REVENUE ANALYSIS
    • 10.2.1 PHARMACEUTICAL PACKAGING MARKET
    • FIGURE 35 REVENUE ANALYSIS FOR KEY COMPANIES IN THE LAST FIVE YEARS
  • 10.3 MARKET SHARE ANALYSIS
    • FIGURE 36 PHARMACEUTICAL PACKAGING MARKET SHARE, BY COMPANY (2020)
    • TABLE 170 PHARMACEUTICAL PACKAGING: DEGREE OF COMPETITION
  • 10.4 RANKING ANALYSIS OF KEY MARKET PLAYERS, 2020
    • FIGURE 37 RANKING OF TOP 5 PLAYERS IN THE PHARMACEUTICAL PACKAGING MARKET, 2020
    • 10.4.1 BERRY GLOBAL INC.
    • 10.4.2 GERRESHEIMER AG
    • 10.4.3 AMCOR PLC
    • 10.4.4 SCHOTT AG
    • 10.4.5 APTARGROUP
  • 10.5 COMPETITIVE EVALUATION QUADRANT (TIER 1)
    • 10.5.1 TERMINOLOGY/NOMENCLATURE
      • 10.5.1.1 STAR
      • 10.5.1.2 PERVASIVE
      • 10.5.1.3 EMERGING LEADER
    • FIGURE 38 PHARMACEUTICAL PACKAGING MARKET (GLOBAL) COMPANY EVALUATION MATRIX FOR TIER 1 COMPANIES, 2020
    • 10.5.2 STRENGTH OF PRODUCT PORTFOLIO
    • FIGURE 39 PRODUCT PORTFOLIO ANALYSIS OF TOP PLAYERS IN THE PHARMACEUTICAL PACKAGING MARKET
    • 10.5.3 BUSINESS STRATEGY EXCELLENCE
    • FIGURE 40 BUSINESS STRATEGY EXCELLENCE OF TOP PLAYERS IN PHARMACEUTICAL PACKAGING MARKET
  • 10.6 COMPETITIVE EVALUATION QUADRANT (OTHER KEY PLAYERS)
    • 10.6.1 TERMINOLOGY/NOMENCLATURE
      • 10.6.1.1 Progressive Companies
      • 10.6.1.2 Responsive Companies
      • 10.6.1.3 Starting Blocks
      • 10.6.1.4 Dynamic Companies
    • FIGURE 41 PHARMACEUTICAL PACKAGING MARKET (GLOBAL) COMPANY EVALUATION MATRIX FOR OTHER KEY PLAYERS, 2020
    • 10.6.2 STRENGTH OF PRODUCT PORTFOLIO (OTHER KEY PLAYERS)
    • FIGURE 42 PRODUCT PORTFOLIO ANALYSIS OF TOP PLAYERS IN THE PHARMACEUTICAL PACKAGING MARKET (OTHER KEY PLAYERS)
    • 10.6.3 BUSINESS STRATEGY EXCELLENCE (OTHER KEY PLAYERS)
    • FIGURE 43 BUSINESS STRATEGY EXCELLENCE OF TOP PLAYERS IN THE PHARMACEUTICAL PACKAGING MARKET (OTHER KEY PLAYERS)
  • 10.7 COMPETITIVE SCENARIO AND TRENDS
    • 10.7.1 PHARMACEUTICAL PACKAGING MARKET
      • 10.7.1.1 Product Launches
    • TABLE 171 PHARMACEUTICAL PACKAGING: PRODUCT LAUNCHES, JANUARY 2018-MAY 2021
      • 10.7.1.2 Deals
    • TABLE 172 PHARMACEUTICAL PACKAGING: DEALS, JANUARY 2018-MAY 2021
      • 10.7.1.3 Investments & Expansions

11 COMPANY PROFILES

  • (Business Overview, Products Offered, Recent Developments, Current Focus and Strategies, Threat From Competition, and Right To Win)**
  • 11.1 BERRY GLOBAL INC.
    • TABLE 173 BERRY GLOBAL: COMPANY OVERVIEW
    • FIGURE 44 BERRY GLOBAL: COMPANY SNAPSHOT
  • 11.2 GERRESHEIMER AG
    • TABLE 174 GERRESHEIMER AG: COMPANY OVERVIEW
    • FIGURE 45 GERRESHEIMER AG: COMPANY SNAPSHOT
  • 11.3 AMCOR PLC
    • TABLE 175 AMCOR PLC: COMPANY OVERVIEW
    • FIGURE 46 AMCOR: COMPANY SNAPSHOT
  • 11.4 SCHOTT AG
    • TABLE 176 SCHOTT AG: COMPANY OVERVIEW
    • FIGURE 47 SCHOTT: COMPANY SNAPSHOT
  • 11.5 APTARGROUP, INC.
    • TABLE 177 APTAR GROUP, INC.: COMPANY OVERVIEW
    • FIGURE 48 APTARGROUP: COMPANY SNAPSHOT
  • 11.6 BECTON, DICKINSON AND COMPANY
    • TABLE 178 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
    • FIGURE 49 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • 11.7 CATALENT, INC.
    • TABLE 179 CATALENT, INC.: COMPANY OVERVIEW
    • FIGURE 50 CATALENT: COMPANY SNAPSHOT
  • 11.8 NIPRO CORPORATION
    • TABLE 180 NIPRO CORPORATION: COMPANY OVERVIEW
    • FIGURE 51 NIPRO CORPORATION: COMPANY SNAPSHOT
  • 11.9 WEST PHARMACEUTICAL SERVICES, INC.
    • TABLE 181 WEST PHARMACEUTICAL SERVICES: COMPANY OVERVIEW
    • FIGURE 52 WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT
  • 11.10 WESTROCK COMPANY
    • TABLE 182 WESTROCK COMPANY: COMPANY OVERVIEW
    • FIGURE 53 WESTROCK COMPANY: COMPANY SNAPSHOT
  • * Business Overview, Products Offered, Recent Developments, Current Focus and Strategies, Threat From Competition, and Right To Win might not be captured in case of unlisted companies.
  • 11.11 OTHERS
    • 11.11.1 ALPLA WERKE ALWIN LEHNER GMBH & CO KG
    • 11.11.2 ARDAGH GROUP S. A.
    • 11.11.3 CCL INDUSTRIES INC.
    • 11.11.4 FRANK NOE EGYPT LTD
    • 11.11.5 GAPLAST GMBH
    • 11.11.6 LONZA GROUP LTD
    • 11.11.7 MONDI GROUP
    • 11.11.8 NOLATO AB
    • 11.11.9 ORIGIN PHARMA PACKAGING
    • 11.11.10 COMAR
    • 11.11.11 PAREKHPLAST INDIA LTD.
    • 11.11.12 SGD PHARMA
    • 11.11.13 SILGAN HOLDINGS INC.
    • 11.11.14 STEVANATO GROUP
    • 11.11.15 VETTER PHARMA INTERNATIONAL GMBH

12 ADJACENT/RELATED MARKETS

  • 12.1 LIMITATIONS
  • 12.2 FLEXIBLE PLASTIC PACKAGING MARKET
    • 12.2.1 FLEXIBLE PLASTIC PACKAGING MARKET OVERVIEW
    • 12.2.2 FLEXIBLE PLASTIC PACKAGING MARKET, BY TYPE
    • TABLE 183 FLEXIBLE PLASTIC PACKAGING MARKET SIZE, BY TYPE, 2018-2025 (USD MILLION)
      • 12.2.2.1 POUCHES
      • 12.2.2.2 ROLLSTOCKS
      • 12.2.2.3 BAGS
      • 12.2.2.4 Wraps
      • 12.2.2.5 Others
    • 12.2.3 FLEXIBLE PLASTIC PACKAGING MARKET, BY MATERIAL
    • TABLE 184 FLEXIBLE PLASTIC PACKAGING MARKET SIZE, BY MATERIAL, 2018-2025 (USD MILLION)
      • 12.2.3.1 Plastic
      • 12.2.3.2 Aluminum Foil
      • 12.2.3.3 Others
    • 12.2.4 FLEXIBLE PLASTIC PACKAGING MARKET, BY APPLICATION
    • TABLE 185 FLEXIBLE PLASTIC PACKAGING MARKET SIZE, BY APPLICATION, 2018-2025 (USD MILLION)
      • 12.2.4.1 Food
      • 12.2.4.2 Beverage
      • 12.2.4.3 Pharma & healthcare
      • 12.2.4.4 Personal care & cosmetics
      • 12.2.4.5 Other applications
    • 12.2.5 FLEXIBLE PLASTIC PACKAGING MARKET, BY REGION
    • TABLE 186 FLEXIBLE PLASTIC PACKAGING MARKET SIZE, BY REGION, 2018-2025 (USD MILLION)
      • 12.2.5.1 APAC
      • 12.2.5.2 North America
      • 12.2.5.3 Europe
      • 12.2.5.4 South America
      • 12.2.5.5 Middle East & Africa
  • 12.3 RIGID PLASTIC PACKAGING MARKET
    • 12.3.1 RIGID PLASTIC PACKAGING MARKET, BY TYPE
    • TABLE 187 RIGID PLASTIC PACKAGING MARKET SIZE, BY TYPE, 2019-2026 (USD BILLION)
      • 12.3.1.1 Bottles & jars
      • 12.3.1.2 Rigid bulk products
      • 12.3.1.3 Trays
      • 12.3.1.4 Tubs, cups, and pots
      • 12.3.1.5 Others
    • 12.3.2 RIGID PLASTIC PACKAGING MARKET, BY RAW MATERIAL
    • TABLE 188 RIGID PLASTIC PACKAGING MARKET SIZE, BY RAW MATERIAL, 2019-2026 (USD BILLION)
      • 12.3.2.1 Bioplastics
      • 12.3.2.2 Polyethylene(PE)
      • 12.3.2.3 Polyethylene Terephthalate (PET)
      • 12.3.2.4 Polystyrene (PS)
      • 12.3.2.5 Polypropylene (PP)
      • 12.3.2.6 Polyvinyl Chloride (PVC)
      • 12.3.2.7 Expanded Polystyrene (EPS)
      • 12.3.2.8 Others (PC, Polyamide)
    • 12.3.3 RIGID PLASTIC PACKAGING MARKET, BY PRODUCTION PROCESS
      • 12.3.3.1 Extrusion
      • 12.3.3.2 Injection molding
      • 12.3.3.3 Blow molding
      • 12.3.3.4 Thermoforming
      • 12.3.3.5 Others
    • 12.3.4 RIGID PLASTIC PACKAGING MARKET, BY APPLICATION
    • TABLE 189 RIGID PLASTIC PACKAGING MARKET SIZE, BY APPLICATION, 2019-2026 (USD BILLION)
      • 12.3.4.1 Food
      • 12.3.4.2 Beverages
      • 12.3.4.3 Healthcare
      • 12.3.4.4 Cosmetics & toiletries
      • 12.3.4.5 Industrial
      • 12.3.4.6 Others
    • 12.3.5 RIGID PLASTIC PACKAGING MARKET, BY REGION
    • TABLE 190 RIGID PLASTIC PACKAGING MARKET SIZE, BY REGION, 2019-2026 (USD BILLION)
      • 12.3.5.1 APAC
      • 12.3.5.2 North America
      • 12.3.5.3 Europe
      • 12.3.5.4 Middle East & Africa
      • 12.3.5.5 South America

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS